DE50114194D1 - Chinoxalinderivate, Zubereitungen diese enthaltend und Verwendung als UV-Filter - Google Patents

Chinoxalinderivate, Zubereitungen diese enthaltend und Verwendung als UV-Filter

Info

Publication number
DE50114194D1
DE50114194D1 DE50114194T DE50114194T DE50114194D1 DE 50114194 D1 DE50114194 D1 DE 50114194D1 DE 50114194 T DE50114194 T DE 50114194T DE 50114194 T DE50114194 T DE 50114194T DE 50114194 D1 DE50114194 D1 DE 50114194D1
Authority
DE
Germany
Prior art keywords
filters
preparations containing
derivatives
chinoxaline
chinoxaline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50114194T
Other languages
English (en)
Inventor
Frank Pfluecker
Hansjuergen Driller
Michael Kirschbaum
Volker Scholz
Hans Neunhoeffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE50114194T priority Critical patent/DE50114194D1/de
Application granted granted Critical
Publication of DE50114194D1 publication Critical patent/DE50114194D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
DE50114194T 2000-03-17 2001-03-06 Chinoxalinderivate, Zubereitungen diese enthaltend und Verwendung als UV-Filter Expired - Lifetime DE50114194D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50114194T DE50114194D1 (de) 2000-03-17 2001-03-06 Chinoxalinderivate, Zubereitungen diese enthaltend und Verwendung als UV-Filter

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10013318A DE10013318A1 (de) 2000-03-17 2000-03-17 Formulierung enthaltend Chinoxalinderivate
PCT/EP2001/002517 WO2001068047A2 (de) 2000-03-17 2001-03-06 Zubereitung enthaltend chinoxalinderivate
DE50114194T DE50114194D1 (de) 2000-03-17 2001-03-06 Chinoxalinderivate, Zubereitungen diese enthaltend und Verwendung als UV-Filter

Publications (1)

Publication Number Publication Date
DE50114194D1 true DE50114194D1 (de) 2008-09-18

Family

ID=7635310

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10013318A Withdrawn DE10013318A1 (de) 2000-03-17 2000-03-17 Formulierung enthaltend Chinoxalinderivate
DE50114194T Expired - Lifetime DE50114194D1 (de) 2000-03-17 2001-03-06 Chinoxalinderivate, Zubereitungen diese enthaltend und Verwendung als UV-Filter

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10013318A Withdrawn DE10013318A1 (de) 2000-03-17 2000-03-17 Formulierung enthaltend Chinoxalinderivate

Country Status (7)

Country Link
US (1) US20030207886A1 (de)
EP (1) EP1267819B1 (de)
JP (1) JP2003526650A (de)
AT (1) ATE403470T1 (de)
AU (1) AU2001237433A1 (de)
DE (2) DE10013318A1 (de)
WO (1) WO2001068047A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111728A1 (de) * 2001-03-09 2002-09-12 Merck Patent Gmbh UV-Filter
DE10238144A1 (de) * 2002-08-15 2004-02-26 Basf Ag Verwendung von Diketopiperazin-Derivaten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
JP2007513184A (ja) * 2003-12-04 2007-05-24 バーテックス　ファーマシューティカルズ　インコーポレイテッド プロテインキナーゼのインヒビターとして有用なキノキサリン
DE102004007966A1 (de) * 2004-02-18 2005-09-08 Merck Patent Gmbh Topische Zusammensetzung, enthaltend mindestens ein Aryloxim und Bisabolol
ES2353448T3 (es) 2007-01-16 2011-03-02 Purdue Pharma L.P. Piperidinas heterocíclico-sustituidas como ligandos de orl-1.
JP5236297B2 (ja) * 2007-03-30 2013-07-17 富士フイルム株式会社 ヘテロ環化合物
TWI448289B (zh) 2007-08-31 2014-08-11 Purdue Pharma Lp 經取代之喹啉型哌啶化合物及其用途
KR100889839B1 (ko) 2007-09-21 2009-03-20 한국화학연구원 신규 2-치환아미노알킬레닐옥시-3-치환페닐에티닐 퀴녹살린유도체
JP5250289B2 (ja) * 2008-03-31 2013-07-31 富士フイルム株式会社 紫外線吸収剤組成物
JP5244437B2 (ja) * 2008-03-31 2013-07-24 富士フイルム株式会社 紫外線吸収剤組成物
CN101644631B (zh) * 2008-08-06 2012-07-04 北京谊安医疗系统股份有限公司 注射泵故障检测装置
JP2010083980A (ja) * 2008-09-30 2010-04-15 Fujifilm Corp 固体高分子材料
DK2440545T3 (da) * 2009-06-12 2019-07-22 Abivax Forbindelser, der er anvendelige til behandling af cancer
US10253020B2 (en) 2009-06-12 2019-04-09 Abivax Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging
AU2010289397B2 (en) 2009-09-03 2016-05-26 Bioenergenix Heterocyclic compounds for the inhibition of PASK
JP5604161B2 (ja) * 2010-04-12 2014-10-08 株式会社ファンケル 日焼け止め化粧料
GB201007286D0 (en) 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
GB201020179D0 (en) 2010-11-29 2011-01-12 Astex Therapeutics Ltd New compounds
KR20130133219A (ko) * 2010-12-23 2013-12-06 머크 샤프 앤드 돔 코포레이션 Crth₂ 수용체 조절제로서의 퀴녹살린 및 아자-퀴녹살린
CN103391932B (zh) 2011-01-05 2015-10-14 拜奥埃内杰尼克斯公司 用于抑制pask的杂环化合物
US8916561B2 (en) 2011-03-02 2014-12-23 Bioenergenix, Llc Substituted quinoxaline compounds for the inhibition of PASK
WO2012119046A2 (en) 2011-03-02 2012-09-07 Bioenergenix Heterocyclic compounds for the inhibition of pask
AR086744A1 (es) * 2011-06-28 2014-01-22 Nippon Soda Co Compuesto heterociclico conteniendo nitrogeno y fungicida para el uso en agricultura y jardineria
WO2013049272A2 (en) 2011-09-29 2013-04-04 Theraceutix, Llc Composition and method for treatment of symptoms associated with various skin conditions
GB201118656D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118675D0 (en) 2011-10-28 2011-12-14 Astex Therapeutics Ltd New compounds
GB201118654D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118652D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
SG10201704095UA (en) 2012-04-24 2017-06-29 Vertex Pharma Dna-pk inhibitors
GB201209613D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201209609D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
EP2757161A1 (de) 2013-01-17 2014-07-23 Splicos miRNA-124 als ein Biomarker für virale Infektion
CN107200749B (zh) 2013-03-12 2019-09-03 沃泰克斯药物股份有限公司 Dna-pk抑制剂
GB201307577D0 (en) 2013-04-26 2013-06-12 Astex Therapeutics Ltd New compounds
CA2916623C (en) 2013-07-05 2021-09-14 Abivax Bicyclic compounds useful for treating diseases caused by retroviruses
EP3057953B1 (de) 2013-10-17 2018-08-15 Vertex Pharmaceuticals Incorporated Co-kristalle von (s)-n-methyl-8-(1-((2'-methyl-[4,5'-bipyrimidin]-6-yl)amino)propan-2-yl)chinolin-4-carboxamid und deuterierten derivaten davon als dna-pk-hemmer
RU2715893C2 (ru) 2014-03-26 2020-03-04 Астекс Терапьютикс Лтд Комбинации ингибитора fgfr и ингибитора igf1r
HUE053654T2 (hu) 2014-03-26 2021-07-28 Astex Therapeutics Ltd FGFR- és CMET-inhibitorok kombinációi a rák kezelésére
JO3512B1 (ar) 2014-03-26 2020-07-05 Astex Therapeutics Ltd مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
EP2974729A1 (de) 2014-07-17 2016-01-20 Abivax Chinolinderivate zur Verwendung bei der Behandlung von Entzündungskrankheiten
JOP20200201A1 (ar) 2015-02-10 2017-06-16 Astex Therapeutics Ltd تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين
US10478494B2 (en) 2015-04-03 2019-11-19 Astex Therapeutics Ltd FGFR/PD-1 combination therapy for the treatment of cancer
EP3353164B1 (de) 2015-09-23 2021-11-03 Janssen Pharmaceutica, N.V. Bi-heteroaryl-substituierte 1,4-benzodiazepine und ihre anwendung in der krebsbehandlung
SI3353177T1 (sl) 2015-09-23 2020-08-31 Janssen Pharmaceutica Nv Triciklični heterocikli za zdravljenje raka
TW201815418A (zh) 2016-09-27 2018-05-01 Vertex Pharma 使用dna破壞劑及dna-pk抑制劑之組合治療癌症的方法
CN111892597B (zh) * 2020-09-01 2023-07-25 山西天宏达安医药科技有限公司 一种喹喔啉基吡啶并吡嗪类化合物及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3366668A (en) * 1965-10-23 1968-01-30 Gen Aniline & Film Corp 2, 2', 4'-tri-hydroxy benzophenone esters of dicarboxylic acids
US3862951A (en) * 1971-09-02 1975-01-28 Syva Co 2{40 Quinoldinyl glycerol compounds
FR2350096A1 (fr) * 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la quinoxaline
DE3309400A1 (de) * 1983-03-16 1984-09-20 Wella Ag 3-amino-tetrahydro-1,3-thiazin-2,4-dione, ihre verwendung sowie diese verbindungen enthaltende hautbehandlungsmittel
US5057594A (en) * 1989-08-17 1991-10-15 Eastman Kodak Company Ultraviolet light-absorbing compounds and sunscreen formulations and polymeric materials containing such compounds or residues thereof
WO1994013647A1 (en) * 1992-12-15 1994-06-23 The Du Pont Merck Pharmaceutical Company (2-quinoxalinyloxy)phenoxypropanoic acids and related derivatives as anticancer agents
DE19506742A1 (de) * 1995-02-27 1996-08-29 Bayer Ag Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
US5856329A (en) * 1995-06-28 1999-01-05 Allergan Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
US5998423A (en) * 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
WO2000061631A1 (en) * 1999-04-12 2000-10-19 Astrazeneca Ab Modified pentapeptide antagonists of the atrial natriuretic peptide clearance receptor
DE10111728A1 (de) * 2001-03-09 2002-09-12 Merck Patent Gmbh UV-Filter
US20050020600A1 (en) * 2003-07-23 2005-01-27 Scherer Warren J. Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists

Also Published As

Publication number Publication date
WO2001068047A2 (de) 2001-09-20
EP1267819B1 (de) 2008-08-06
DE10013318A1 (de) 2001-09-20
US20030207886A1 (en) 2003-11-06
JP2003526650A (ja) 2003-09-09
AU2001237433A1 (en) 2001-09-24
WO2001068047A3 (de) 2002-03-07
EP1267819A2 (de) 2003-01-02
ATE403470T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
DE50114194D1 (de) Chinoxalinderivate, Zubereitungen diese enthaltend und Verwendung als UV-Filter
ATE508116T1 (de) Ionische uv-a-sonnenschutzmittel und zusammensetzungen, die diese enthalten
ATE253574T1 (de) S-triazinverbindungen und ihre verwendung als uv- filter
BR0307335A (pt) Composições protetoras contra sol e diidropiridinas e diidropiranos
BR0011766A (pt) Misturas de micropigmentos
DE69408309D1 (de) Mittel zum künstlichen sonnenbräunen und zum schutz der haut gegen uv-strahlen
WO2001085106A3 (de) Kosmetisches mittel enthaltend 2-furanonderivate
ATE429436T1 (de) Silanmerocyaninsulphonderivate, photoprotektive zusammensetzungen damit, verwendung davon als uv- filter
ATE380054T1 (de) Topisches mittel zur dermatologischen verwendung enthaltend 4-hydroxyphenyl-alpha-d-glucopyranosid
WO2007128840A3 (en) Use of troxerutin to quench the fluorescence of disodium phenyl dibenzimidazole tetrasulfonate
EP1506772A3 (de) Ästhetisch und SPF verbesserte UV-Sonnenschutzmittel, die Glasmikrosphären enthalten
MX2009010535A (es) Protector solar y composiciones para el cuidado personal que comprenden un copolimero seleccionado.
MX2009010484A (es) Composiciones de protectores solares que comprenden un terpolimero aleatorio.
CA2243860A1 (fr) Compositions photoprotectrices comprenant un benzylidene camphre et/ou un dibenzoylmethane et/ou une triazine et un tartrate de dialkyle ; utilisations en cosmetique
PT1235571E (pt) Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino
DE59908706D1 (de) Verwendung von cholesterich-flüssigkristallinen Polymeren als UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
WO2002080878A3 (fr) Produit bronzant et filtrant
BR9912035A (pt) Composições de filtro solar
ATE265202T1 (de) Sonnenschutzzusammensetzungen und deren verwendung
DE50210275D1 (de) Trizyklische chinoxalinderivate als uv-filter
DE60331637D1 (de) Organosilikon-derivate von amino-hydroxybenzophenonen und ihre verwendung als uv-a-filter in kosmetischen zubereitungen
ATE308306T1 (de) Verwendung von wasserunlöslichen linearen poly- alpha-glucan als uv-filter
JP2700601B2 (ja) 天然紫外線吸収剤およびこれを含む化粧品
WO2001074320A3 (de) Verwendung von protease-inhibitoren in der kosmetik und pharmazie
AU2002224822A1 (en) Cosmetic skin treatment, care or protection composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition